Ken Yamazumi
Directeur/Bestuurslid bij SanBio, Inc.
Profiel
Ken Yamazumi is currently the Director & External Auditor at SanBio, Inc. He was previously the Chairman & President at Kirin Pharma Co. Ltd.
from 2007 to 2008, and the Representative Director & Executive Vice President at Kyowa Kirin Co., Ltd.
from 2011 to 2012.
Mr. Yamazumi received his undergraduate degree from the University of Tokyo in 1973.
Actieve functies van Ken Yamazumi
| Bedrijven | Functie | Begin |
|---|---|---|
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Ken Yamazumi
| Bedrijven | Functie | Einde |
|---|---|---|
| KYOWA KIRIN CO. LTD. | Directeur/Bestuurslid | 22-03-2012 |
Kirin Pharma Co. Ltd.
 Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Voorzitter | 06-10-2008 |
Opleiding van Ken Yamazumi
| University of Tokyo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Kirin Pharma Co. Ltd.
Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |